Aspetti endocrini della neurofibromatosi tipo 1

Friedman JM (1993–2018) Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RA et al (eds) SourceGeneReviews, University of Washington, Seattle

Hegedus B, Yeh TH, Lee DY et al. (2008) Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hum Mol Genet 17(19):2956–2966

Sani I, Albanese A (2017) Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma. Horm Res Paediatr 87(3):179–188

Gruber LM, Erickson D, Babovic-Vuksanovic D et al. (2017) Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol (Oxf) 86(1):141–149

Gieldon L, Masjkur JR, Richter S et al. (2018) Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1. Eur J Endocrinol 178(2):K1–K9

Petramala L, Giustini S, Zinnamosca L et al. (2012) Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease). Arch Dermatol Res 304(4):325–331

Schnabel C, Jett K, Friedman JM et al. (2013) Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study. Jt Bone Spine 80(3):315–319

Lammert M, Friedman JM, Roth HJ et al. (2006) Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 43(10):810–813

Koga M, Yoshida Y, Imafuku S (2016) Nutritional, muscular and metabolic characteristics in patients with neurofibromatosis type 1. J Dermatol 43(7):799–803

Martins AS, Jansen AK, Rodrigues LO et al. (2018) Increased insulin sensitivity in individuals with neurofibromatosis type 1. Arch Endocrinol Metab 62(1):41–46

Nabi J (2013) Neurofibromatosis type 1 associated with Hashimoto’s thyroiditis: coincidence or possible link. Case Rep Neurol Med 2013:910656

Ercolino T, Lai R, Giachè V et al. (2014) Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. Gene 536(2):332–335